SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-030724
Filing Date
2017-02-03
Accepted
2017-02-03 16:12:37
Documents
2
Effectiveness Date
2017-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d330671d8k.htm DEFA14A 23563
2 EX-10.1 d330671dex101.htm EX-10.1 315796
  Complete submission text file 0001193125-17-030724.txt   340368
Mailing Address 255 STATE STREET 6TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 6TH FLOOR BOSTON MA 02109 617-225-4348
Tokai Pharmaceuticals Inc (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36620 | Film No.: 17572232
SIC: 2834 Pharmaceutical Preparations